Asia Beat: Vietnam - the next big(gish) thing?
This article was originally published in Scrip
Anyone who takes a passing interest in where consumer goods such as clothes and bags are made may have noticed a partial shift away from China over the past few years and the steady emergence of Vietnam as a production base.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.